Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 160.113 million compared to CNY 218.894 million a year ago. Operating loss was CNY 14.304 million compared to CNY 15.824 million a year ago. Net loss was CNY 4.115 million compared to CNY 2.244 million a year ago. Basic loss per share from continuing operations was CNY 0.0338 compared to CNY 0.0184 a year ago.